Spineology Clinical Outcomes Trial: An IDE Investigation
Status: | Recruiting |
---|---|
Conditions: | Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 21 - 80 |
Updated: | 12/1/2016 |
Start Date: | February 2015 |
End Date: | February 2019 |
Contact: | Rose Griffith |
Email: | Rgriffith@spineology.com |
Phone: | 651-256-8503 |
Spineology Clinical Outcomes Trial: An Investigation Device Exempt (IDE) Performance Goal Clinical Investigation
This study evaluates the safety and effectiveness of the Spineology Interbody Fusion System
(SIFS) in an instrumented interbody lumbar fusion in subjects presenting with symptomatic
single-level lumbar degenerative disc disease.
(SIFS) in an instrumented interbody lumbar fusion in subjects presenting with symptomatic
single-level lumbar degenerative disc disease.
This regulated prospective, multi-center, Institutional Review Board (IRB) approved
single-arm performance goal clinical investigation will be conducted at a maximum of 15
centers with no more than 102 subjects being enrolled and treated.
It is anticipated that enrollment will be compete within 24 months. Subjects will be
actively evaluated to 24-months postoperative and depending on enrollment duration, may be
remotely assessed through self-administered surveys at 36- and 48-months.
The primary endpoint, assessed at 24-months postoperative, is a composite score that
includes pain, function, fusion and safety assessments.
single-arm performance goal clinical investigation will be conducted at a maximum of 15
centers with no more than 102 subjects being enrolled and treated.
It is anticipated that enrollment will be compete within 24 months. Subjects will be
actively evaluated to 24-months postoperative and depending on enrollment duration, may be
remotely assessed through self-administered surveys at 36- and 48-months.
The primary endpoint, assessed at 24-months postoperative, is a composite score that
includes pain, function, fusion and safety assessments.
Inclusion Criteria:
- Skeletally mature;
- Confirmed symptomatic single-level lumbar degenerative disc disease (DDD) between L2
and S1;
- Minimum low back VAS pain score of 40mm;
- Minimum ODI score of 40;
- Received at least 6-months of conservative care; and
- Willing and able to comply with protocol evaluations and provide informed consent.
Exclusion Criteria:
- Previous fusion or total disc replacement at the index level;
- Greater than Grade I spondylolisthesis;
- Has symptomatic multi-level lumbar DDD;
- Active systemic infection or infection at the local surgical site;
- Active or suspected malignancy;
- Body Mass Index of greater than or equal to 40;
- Significant metabolic bone disease;
- Taking medication known to interfere with bone healing;
- Has a current substance abuse disorder;
- Has a somatoform, dissociative, eating or psychotic disorder;
- Waddell Signs of inorganic behavior;
- Current tobacco user;
- Is a prisoner;
- If female, pregnant or contemplating pregnancy during follow-up period; or
- Enrolled in a concurrent clinical investigation that may confound the findings of the
current investigation
We found this trial at
10
sites
Deland, Florida 32720
Principal Investigator: Stephane Lavoie, M.D.
Phone: 386-734-9122
Click here to add this to my saved trials
75 Francis street
Boston, Massachusetts 02115
Boston, Massachusetts 02115
(617) 732-5500
Principal Investigator: John Chi, M.D., MPH
Phone: 617-732-8527
Brigham and Women's Hosp Boston’s Brigham and Women’s Hospital (BWH) is an international leader in...
Click here to add this to my saved trials
Buffalo, New York
Principal Investigator: John Pollina, M.D.
Phone: 716-888-4811
Click here to add this to my saved trials
Clinton, Maryland 20735
Principal Investigator: Faheem Sandhu, M.D., PhD
Phone: 202-444-1210
Click here to add this to my saved trials
Kalamazoo, Michigan 39007
Principal Investigator: Alain Fabi, M.D.
Click here to add this to my saved trials
Peabody, Massachusetts 01960
Principal Investigator: Richard Ozuna, M.D.
Phone: 978-818-6459
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Mohamad Bydon, M.D.
Phone: 507-293-1963
Click here to add this to my saved trials
Shreveport, Louisiana 71101
Principal Investigator: Pierce Nunley, M.D.
Phone: 318-629-5585
Click here to add this to my saved trials
South Burlington, Vermont 05403
Principal Investigator: Martin Krag, M.D.
Phone: 802-656-9912
Click here to add this to my saved trials
Thibodaux, Louisiana 70901
Principal Investigator: Deepak Awasthi, M.D.
Phone: 985-493-4510
Click here to add this to my saved trials